Description
AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 with a good affinity of Kd of 1.4µM. AVJ16 interferes with IGF2BP1 binding target mRNA to regulate gene expression and translation[1]